Pittenger & Anderson Inc Repligen Corp Transaction History

Pittenger & Anderson Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$138.42 - $180.31 $1,522 - $1,983	11 Added 20.37%	65 $9,000
Q1 2023 May 10, 2023	BUY	$154.26 - $198.1 $4,319 - $5,546	28 Added 107.69%	54 $9,000
Q3 2022 Nov 15, 2022	BUY	$160.42 - $256.21 $641 - $1,024	4 Added 18.18%	26 $5,000
Q3 2021 Nov 12, 2021	BUY	$194.77 - $324.21 $973 - $1,621	5 Added 29.41%	22 $6,000
Q1 2021 May 12, 2021	BUY	$180.37 - $226.26 $1,082 - $1,357	6 Added 54.55%	17 $3,000
Q4 2020 Feb 11, 2021	BUY	$148.08 - $206.57 $444 - $619	3 Added 37.5%	11 $2,000
Q3 2020 Nov 10, 2020	BUY	$122.51 - $158.27 $980 - $1,266	8 New	8 $1,000

481

56.3M

251K

458K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.03B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Pittenger & Anderson Inc, based on Form 13F filings with the SEC.

Stay updated on Pittenger & Anderson Inc with notifications on news.